机构:[1]The Fifth Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China,[2]Department of Oncology Rehabilitation, Jincheng People’s Hospital, Jincheng, China,[3]Department of Anesthesiology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China,[4]Department of Anesthesiology, Jincheng People’s Hospital, Jincheng, China,[5]Department of Rehabilitation, GuangDong Second Traditional Chinese Medicine Hospital, Guangzhou, China
This work was supported by funding from the Project of
Traditional Chinese Medicine Bureau of Guangdong Province
(20203002) and Jincheng People’s Hospital (JSY-2021D009).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|3 区生物学
小类|3 区遗传学
最新[2025]版:
大类|3 区生物学
小类|3 区遗传学
第一作者:
第一作者机构:[1]The Fifth Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China,[2]Department of Oncology Rehabilitation, Jincheng People’s Hospital, Jincheng, China,
共同第一作者:
通讯作者:
通讯机构:[1]The Fifth Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China,[5]Department of Rehabilitation, GuangDong Second Traditional Chinese Medicine Hospital, Guangzhou, China
推荐引用方式(GB/T 7714):
Yue Ting,Li Jingjing,Liang Manguang,et al.Identification of the KCNQ1OT1/ miR-378a-3p/ RBMS1 Axis as a Novel Prognostic Biomarker Associated With Immune Cell Infiltration in Gastric Cancer[J].Frontiers in genetics.2022,13:928754.doi:10.3389/fgene.2022.928754.
APA:
Yue Ting,Li Jingjing,Liang Manguang,Yang Jiaman,Ou Zhiwen...&Fan Dehui.(2022).Identification of the KCNQ1OT1/ miR-378a-3p/ RBMS1 Axis as a Novel Prognostic Biomarker Associated With Immune Cell Infiltration in Gastric Cancer.Frontiers in genetics,13,
MLA:
Yue Ting,et al."Identification of the KCNQ1OT1/ miR-378a-3p/ RBMS1 Axis as a Novel Prognostic Biomarker Associated With Immune Cell Infiltration in Gastric Cancer".Frontiers in genetics 13.(2022):928754